Clinical Trials on Diabetic Peripheral Neuropathy (DPN) in Korea, Democratic People's Republic of
Total 106 results
-
BayerCompletedDiabetic NephropathiesHong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
Tehran University of Medical SciencesCompletedDiabetes Mellitus | Chronic Kidney Disease | Radiocontrast-Induced NephropathyIran, Islamic Republic of
-
Boehringer IngelheimCompletedHypertension | Diabetic NephropathiesTaiwan, United States, Canada, Thailand, Korea, Republic of, Argentina, Australia, Brazil, Mexico, New Zealand
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedNeuropathic PainUnited States, Korea, Republic of, Germany, Hungary, Canada, Denmark, Sweden, Poland, Romania, South Africa, Bulgaria, Croatia, Puerto Rico